# Hypersensitivity to Phosphodiesterase 3 Inhibition in Post-Traumatic Headache

> **NCT05595993** · NA · UNKNOWN · sponsor: **Danish Headache Center** · enrollment: 21 (estimated)

## Conditions studied

- Post-Traumatic Headache

## Interventions

- **DRUG:** Cilostazol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05595993
- **Lead sponsor:** Danish Headache Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-25
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05595993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05595993, "Hypersensitivity to Phosphodiesterase 3 Inhibition in Post-Traumatic Headache". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05595993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*